Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

NCT01339988 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Leukemias
Chronic Leukemias
Myelodysplastic Syndrome
Juvenile Myelomonocytic Leukemia

Interventions

DRUG: Busulfan/Cyclophosphamide

Sponsor

Tel-Aviv Sourasky Medical Center